Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00143806
What this trial is testing

Transitioning From Cyclosporine to Alefacept in Psoriasis

Who this might be right for
Psoriasis
University of Medicine and Dentistry of New Jersey 13
Not applicableEnded earlyNCT01156532
What this trial is testing

Clinical Effectiveness and Impact on Health-related Quality of Life in Peruvian Patients With Psoriasis After 16 Weeks of Adalimumab Therapy

Who this might be right for
Moderate to Severe Psoriasis
AbbVie (prior sponsor, Abbott) 30
Post-approval studies (Phase 4)Study completedNCT05510063
What this trial is testing

Pharmacokinetics, Efficacy, Safety, and Immunogenicity of SB5 Versus Humira in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Samsung Bioepis Co., Ltd. 371
Testing effectiveness (Phase 2)Study completedNCT05268016
What this trial is testing

Efficacy and Safety of ME3183 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Meiji Pharma USA Inc. 132
Post-approval studies (Phase 4)WithdrawnNCT03146247
What this trial is testing

Analysis of the Pathogenesis of Itch in Response to Apremilast Therapy in Psoriasis Patients

Who this might be right for
Moderate to Severe Plaque Psoriasis
Diamant Thaci
Large-scale testing (Phase 3)Study completedNCT03478787
What this trial is testing

Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 327
Post-approval studies (Phase 4)Study completedNCT02425826
What this trial is testing

Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.

Who this might be right for
Parapsoriasis
Amgen 221
Not applicableNot Yet RecruitingNCT07626788
What this trial is testing

Pentoxifylline Add-On Therapy for Mild-to-Moderate Plaque Psoriasis

Who this might be right for
Psoriasis
Wasuchon Chaichan 140
Early research (Phase 1)Study completedNCT01258088
What this trial is testing

Safety Study of Ointment for the Treatment of Plaque-type Psoriasis

Who this might be right for
Plaque-type Psoriasis
Pfizer 16
Testing effectiveness (Phase 2)Study completedNCT05896527
What this trial is testing

Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company 229
Post-approval studies (Phase 4)Study completedNCT05891964
What this trial is testing

Outcome of Treatment With Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis at Tertiary Care Hospital.

Who this might be right for
Plaque Psoriasis
Jinnah Postgraduate Medical Centre 50
Post-approval studies (Phase 4)Study completedNCT03020199
What this trial is testing

Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 196
Early research (Phase 1)Looking for participantsNCT06888193
What this trial is testing

Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Who this might be right for
Moderate to Severe Plaque PsoriasisPsoriatic ArthritisAxial Spondyloarthritis+1 more
UCB Biopharma SRL 20
Testing effectiveness (Phase 2)Study completedNCT02494479
What this trial is testing

Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Cellceutix Corporation 115
Testing effectiveness (Phase 2)Active Not RecruitingNCT07148414
What this trial is testing

SPY072 in Rheumatic Disease

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisAxial Spondyloarthritis+5 more
Spyre Therapeutics, Inc. 285
Testing effectiveness (Phase 2)Study completedNCT05283135
What this trial is testing

High Dose Risankizumab for Psoriasis

Who this might be right for
Psoriasis
Oregon Medical Research Center 20
Not applicableStudy completedNCT05388916
What this trial is testing

A Real-world Study to Assess Safety and Effectiveness of Secukinumab in Pediatric Plaque Psoriasis Patients in China

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Novartis Pharmaceuticals 42
Testing effectiveness (Phase 2)Study completedNCT00669916
What this trial is testing

A Study Comparing AIN457 to Placebo in Subjects With a Diagnosis of Moderate to Severe Stable Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)Study completedNCT01001468
What this trial is testing

Study to Assess VB-201 in Patients With Psoriasis

Who this might be right for
Active Plaque Psoriasis
Vascular Biogenics Ltd. operating as VBL Therapeutics 185
Early research (Phase 1)UnknownNCT02999776
What this trial is testing

Laser-assisted Topical Administration of Etanercept (Enbrel®) in Patients With Mild to Moderate Plaque-type Psoriasis

Who this might be right for
Psoriatic Plaque
Pantec Biosolutions AG 30
Next Page